Cetuximab
From SNPedia
Cetuximab is the generic name for a chimeric monoclonal antibody targeting (and thus inhibiting) the epidermal growth factor (EGFR) receptor. Cetuximab is most commonly used for the treatment of metastatic colorectal cancer and head and neck cancer. Cetuximab is marked under the brand name erbitux. Wikipedia
SNPs influencing the efficacy of cetuximab include:
